Legend Biotech (LEGN) Competitors

Legend Biotech (NASDAQ:LEGN) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Do analysts rate LEGN or BNTX?

Legend Biotech presently has a consensus price target of $74.73, suggesting a potential upside of 148.51%. BioNTech has a consensus price target of $142.08, suggesting a potential upside of 39.68%. Given Legend Biotech's stronger consensus rating and higher probable upside, equities analysts plainly believe Legend Biotech is more favorable than BioNTech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Legend Biotech	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92
BioNTech	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.89

Do insiders & institutionals believe in LEGN or BNTX?

70.9% of Legend Biotech shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 0.0% of Legend Biotech shares are held by company insiders. Comparatively, 19.2% of BioNTech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the media favor LEGN or BNTX?

In the previous week, Legend Biotech had 20 more articles in the media than BioNTech. MarketBeat recorded 39 mentions for Legend Biotech and 19 mentions for BioNTech. BioNTech's average media sentiment score of 1.19 beat Legend Biotech's score of 0.82 indicating that BioNTech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Legend Biotech	13 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
BioNTech	9 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, LEGN or BNTX?

Legend Biotech has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.

Which has better earnings and valuation, LEGN or BNTX?

BioNTech has higher revenue and earnings than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than BioNTech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Legend Biotech	$728.30M	7.58	-$518.25M	-$0.59	-50.97
BioNTech	$2.75B	8.90	$1.01B	-$3.40	-29.92

Does the MarketBeat Community favor LEGN or BNTX?

BioNTech received 56 more outperform votes than Legend Biotech when rated by MarketBeat users. However, 73.02% of users gave Legend Biotech an outperform vote while only 47.44% of users gave BioNTech an outperform vote.

Company	Underperform	Outperform
Legend Biotech	Outperform Votes 92 73.02%	Underperform Votes 34 26.98%
BioNTech	Outperform Votes 148 47.44%	Underperform Votes 164 52.56%

Is LEGN or BNTX more profitable?

BioNTech has a net margin of -15.16% compared to Legend Biotech's net margin of -66.92%. BioNTech's return on equity of -2.35% beat Legend Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Legend Biotech	-66.92%	-29.69%	-19.45%
BioNTech	-15.16%	-2.35%	-2.05%

Summary

BioNTech beats Legend Biotech on 12 of the 19 factors compared between the two stocks.